FDA Drug Development Strategy Includes Initiating Meetings With Firms
Executive Summary
FDA will seek legislation empowering the agency to initiate meetings with industry on drug development, Acting Commissioner Lester Crawford, PhD, said
You may also be interested in...
AIDS Drug Combos Still Moving Slowly After FDA Guidance
GlaxoSmithKline and Boehringer Ingelheim are in discussions with FDA on a Combivir/Viramune co-package submission after signing a "letter of intent" to develop the product
AIDS Drug Combos Still Moving Slowly After FDA Guidance
GlaxoSmithKline and Boehringer Ingelheim are in discussions with FDA on a Combivir/Viramune co-package submission after signing a "letter of intent" to develop the product
Warning Letter “Templates” Likely Part Of GMP Proposal In August
The Center for Drug Evaluation & Research is likely to propose warning letter "templates" as part of its revisions to the Good Manufacturing Practices regulations coming out in August